Evidence map›Paper›PMID 7531954›Full record

ArticleThe American journal of pathology1995

Identification of tissue-infiltrating lymphocytes expressing PEN5, a mucin-like glycoprotein selectively expressed on natural killer cells.

E Vivier, M Munroe, P Ariniello, P Anderson

Abstract read
In one paragraph

Article in The American journal of pathology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Analysis of islet inflammation in human type 1 diabetes.Clinical and experimental immunology · 2009
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

E VivierCentre d'Immunologie, INSERM-CNRS, Marseille, France.
M Munroe
P Ariniello
P Anderson
Centre National de la Recherche Scientifique · FR

Funding

ROLE OF PSGL 1 IN NATURAL KILLER CELL FUNCTIONR01CA053595 · NCI · DANA-FARBER CANCER INSTITUTE · PI ANDERSON, PAUL J. · 1991 to 2003
$786k
NCI NIH HHS CA53595
6 · The paper itself

Abstract

PEN5 is a carbohydrate epitope selectively expressed on peripheral blood natural killer cells. We have used a monoclonal antibody reactive with PEN5 to survey the expression of PEN5+ large granule lymphocytes in a variety of human tissues. PEN5+ cells are scattered throughout lymphoid (eg, lymph node, tonsil, thymus, spleen, and intestine) and nonlymphoid (eg, liver, esophagus, lung, and uterus) organs. Due to their relatively abundant cytoplasm, these cells are somewhat larger than resting tissue lymphocytes. The majority of splenic (87 +/- 13%, n = 5) and hepatic (92 +/- 6%, n = 5) PEN5+ lymphocytes coexpress TIA-1, a cytotoxic granule protein found in natural killer cells. In some tissues (eg, tonsil and Peyer's patch), however, relatively few PEN5+ lymphocytes coexpress TIA-1, possibly reflecting different stages of activation or differentiation. Our results indicate that PEN5 may be a useful marker of tissue-infiltrating natural killer cells and reveal these cells to be surprisingly abundant in lymphoid tissues.

Indexed as

Membrane ProteinsProteinsAmino SugarsAntigens, CDAntigens, Differentiation, T-LymphocyteAntigens, SurfaceCD56 AntigenCell DifferentiationColonHumansKiller Cells, NaturalLiverLungLymphocytesLymphoid TissueMicroscopy, ElectronAmino SugarsAntigens, CDAntigens, Differentiation, T-LymphocyteAntigens, SurfaceCD56 AntigenMembrane ProteinsPen5 antigen, humanPoly(A)-Binding ProteinsPolysaccharidesProteinsRNA-Binding ProteinsT-Cell Intracellular Antigen-1TIA1 protein, human

Identifiers

PMID7531954
PMCPMC1869861
OpenAlexW52977401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.